Drug search by name

Xeljanz and Tuberculosis

Result of checking the interaction of drug Xeljanz and disease Tuberculosis for safety when used together.

Check result:

Xeljanz <> Tuberculosis

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Before initiating tofacitinib, patients should be screened for latent or active tuberculosis infection. Anti-tuberculosis therapy should also be considered before initiation of tofacitinib in patients with a history of latent or active tuberculosis in whom an adequate course of treatment cannot be confirmed, and for patients with a negative test for latent tuberculosis but having risk factors for tuberculosis infection. Patients should be closely monitored for any signs and symptoms of tuberculosis, including those patients who tested negative for latent tuberculosis infection before initiating therapy. Patients with latent tuberculosis should be treated with standard therapy before initiation of treatment and should be closely screen for whether initiating anti-tuberculosis therapy is appropriate.

Xeljanz

Generic Name: tofacitinib

Brand Name: Xeljanz, Xeljanz XR

Synonyms: n.a.

What is Xeljanz?